Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FBF48
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $96,111
Award facts
- Contract value 100% obligated
- $96,110.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $96,110.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pens in 2 mL formulations, with an ultimate completion date of September 25, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems.
AmerisourceBergen's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this prime contract vehicle, the company serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard. Cosentyx, a biologic immunosuppressant used to treat autoimmune conditions, represents one component of the extensive pharmaceutical portfolio the company delivers under this master contract arrangement, which demonstrates AmerisourceBergen's capability to fulfill complex federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FBF48?
SPE2DB25FBF48 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FBF48 worth?
The government has obligated $96,111 on SPE2DB25FBF48.
Is contract SPE2DB25FBF48 an order under another contract?
Yes. SPE2DB25FBF48 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FBF48 competed?
The extent of competition for SPE2DB25FBF48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award